25.05 Johnson&Johnson FDA 10 2017 .

Johnson&Johnson, 2017 . Janssen FDA 10 25 , FirstWord Pharma.

C simeprevir, FDA. 2013 .

, Janssen ibrutinib, Pharmacyclics, daratumumab, Genmab.

GlaxoSmithKline sirukumab, 2012 .

guselkumab Invega (paliperidone), , , .

Johnson&Johnson, 2012 . , 2009 ., 17% 7% .

- . , 3 . 2017 . .

. 2017 . 6 .